HealthCare Institute of New Jersey Statement on the Federal Trade Commission’s Final HSR Premerger Notification Rules
Trenton, October 11, 2024 ― The HealthCare Institute of New Jersey released the following statement concerning the Federal Trade Commission’s (FTC) final Hart-Scott-Rodino (HSR) premerger notification rules issued yesterday: “The final HSR rules as issued by the Federal Trade Commission will impose a significant burden on the future of New Jersey’s life sciences community and our […]
New Jersey’s Cutting-Edge Medical Technology Sector Saves Lives Around the World
By Chrissy Buteas, President and Chief Executive Officer HealthCare Institute of New Jersey (HINJ) Published September 24, 2024 New Jersey, long hailed as the “Medicine Chest of the World,” boasts a thriving life sciences community and is a beacon of global medical innovation. It’s a source of pride that the treatments and cures saving lives worldwide […]
HealthCare Institute of New Jersey Statement on the Federal Trade Commission’s Action Against Pharmacy Benefit Managers
Trenton, September 20, 2024 ― The HealthCare Institute of New Jersey (HINJ – www.hinj.org), released the following statement concerning the Federal Trade Commission’s (FTC) legal action against the three largest pharmacy benefit managers (PBMs): “HINJ applauds the FTC’s lawsuit filed today against PBMs for their anticompetitive and unfair practices that harm patients by artificially increasing […]
HINJ is Hiring!
Trenton, September 3, 2024 ― We are excited to announce an opening for the position of Director of Government and External Relations. This pivotal role will represent HINJ before government officials and engage stakeholders to build support of public policies that protect patient access and innovation and highlight and promote the value New Jersey’s life […]
HealthCare Institute of New Jersey Issues Statement on Inflation Reduction Act’s New List of Medicines Subject to Price Controls
Trenton, August 15, 2024 ― The HealthCare Institute of New Jersey released the following statement concerning the Administration’s announcement of the next selected prescription medicines subject to government price setting: “Government price controls are not the way to lower health care costs. These price controls run counter to America’s longstanding global leadership on innovation – […]
HealthCare Institute of New Jersey Elects New Board Leadership
Trenton, August 5, 2024 ― The HealthCare Institute of New Jersey has announced new officers of its Board of Trustees and the leadership of its Steering Committee, effective July 1. Leo Farber, Vice President and Head of U.S. Government Affairs, Novartis, was elected Chair of the Board. Mr. Farber joined Novartis in 2014 and has […]
Federal Reports Find PBMs Drive Up Drug Costs, Pocket the Money. Patients Need Protection.
Chrissy Buteas Special to the USA TODAY NetworkJuly 30, 2024 A new study by the Federal Trade Commission as well as a report issued by the House Oversight Committeehave confirmed what many policymakers and health policy experts have been saying for the last few years: little-known middlemen in the healthcare sector, called pharmacy benefit managers, or […]
HealthCare Institute of New Jersey Holds “Diversity in the Healthcare Workforce” Panel Featuring Congresswoman Bonnie Watson Coleman
Trenton, July 17, 2024 ― The HealthCare Institute of New Jersey held a panel discussion focused on diversity in the healthcare workforce on Tuesday, July 16, 2024, featuring Congresswoman Bonnie Watson Coleman as the keynote speaker and panelist. The panel discussion was moderated by Assembly Health Committee Chairman Dr. Herb Conaway. HINJ, a trade association […]
New HINJ CEO Buteas Eager for Honest Discussion on Costs of Drug Development, Prescription Prices (ROI-NJ.com)
Veteran lobbyist says less than 10% of health care dollar is spent on prescription drugs — percentage that has not changed since 1960s June 4, 2024 ― Chrissy Buteas quickly and succinctly rattled off why she is excited to be the new CEO of the HealthCare Institute of New Jersey. “Iconic industry that saves lives,” she […]
For New Head of Healthcare Institute, Retention is as Important as Attraction When it Comes to Industry Growth in State (ROI-NJ.com)
Buteas is all about helping N.J. grow biopharma and medical technology sectors, but stresses need to acknowledge, appreciate global companies already here June 4, 2024 ― Whether she’s at the New Jersey pavilion or walking the floor at this week’s BIO International Conference in San Diego, Chrissy Buteas — the new CEO of the HealthCare […]